Arrhythmogenic Effects of Genetic Mutations Affecting Potassium Channels in Human Atrial Fibrillation: A Simulation

Rebecca Belletti1, Lucia Romero1, Laura Martinez-Mateu2

  • 1Centro de Investigación e Innovación en Bioingeniería, Universitat Politècnica de València, Valencia, Spain.

Insights

Genetic mutations in potassium channels increase atrial fibrillation risk. Three specific mutations (KCNH2 T895M, KCNH2 T436M, KCNE3-V17M) create a more arrhythmogenic substrate, promoting rotor initiation and maintenance.

Area of Science:

  • Cardiovascular Electrophysiology
  • Computational Biology
  • Medical Genetics

Background:

  • Potassium channel gene mutations are linked to atrial fibrillation (AF) in asymptomatic individuals.
  • Gain-of-function mutations in KCNH2 and KCNE3 are implicated in AF pathogenesis.

Purpose of the Study:

  • To investigate the arrhythmogenic potential of KCNH2 T895M, KCNH2 T436M, and KCNE3-V17M mutations.
  • To model and simulate the electrophysiological effects of these mutations on atrial tissue.

Main Methods:

  • Utilized a genetic algorithm to adjust ionic current parameters in the Courtemanche human atrial myocyte model.
  • Analyzed action potentials, ionic currents, and restitution properties in pulmonary vein, right atrium, and left atrium models.
  • Assessed atrial tissue susceptibility to spiral wave generation and temporal vulnerability.

Main Results:

  • All three mutations increased arrhythmogenicity, shortening action potential duration and flattening restitution curves.
  • Mutations enhanced temporal vulnerability, promoting rotor initiation and sustained spiral wave activity.
  • KCNE3-V17M exhibited the most significant pro-arrhythmic effects; pulmonary vein tissue was most susceptible to rotor initiation, while left atrium sustained rotors longer.

Conclusions:

  • KCNH2 T895M, KCNH2 T436M, and KCNE3-V17M mutations promote atrial arrhythmias by facilitating rotor formation and maintenance.
  • Tissue-specific differences in susceptibility were observed, with pulmonary vein and left atrium being more vulnerable.
  • Findings offer insights into AF mechanisms and potential for patient-specific therapies targeting these genetic variants.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.4K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.5K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
225
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.1K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.8K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K